Skip to main content

Olumiant and Alcohol/Food Interactions

There is 1 alcohol/food/lifestyle interaction with Olumiant (baricitinib).


High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)

Moderate Potential Hazard, Moderate plausibility

baricitinib - hyperlipemia

In controlled clinical trials in patients with rheumatoid arthritis, baricitinib treatment was associated with dose-related increases in lipid parameters including total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol. Lipid parameters should be assessed at baseline and about 12 weeks after initiation of therapy in patients with rheumatoid arthritis. Patients should be managed according to clinical guidelines for the management of hyperlipidemia.


  1. "Product Information. Olumiant (baricitinib)." Lilly, Eli and Company (2018):

Olumiant drug interactions

There are 397 drug interactions with Olumiant (baricitinib).

Olumiant disease interactions

There are 13 disease interactions with Olumiant (baricitinib) which include:

Report options

Share by QR Code
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.